Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Acta Oncol. 2010 Oct;49(7):964–971. doi: 10.3109/0284186X.2010.498440

Figure 1.

Figure 1

(a) The Cu-ATSM PET image for the patient, (b) the dose prescription map, (c) the substructures corresponding to five dose prescription levels, (d) an example of the optimised dose.